|
⚲
|
| Keyboard |
| Nolan Lisa
✚
|
|
|---|---|
| CIK # | 0001661400 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001661400] | |
| 4 | [0001661400] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Rexahn Pharmaceuticals Inc | |
| Nolan Lisa | |
| Relmada Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Rexahn Pharmaceuticals Inc RNN
Restricted Stock Units · derivative
|
2019-02-28 | Option exercise | 1,625 | $0.00 | |
|
Rexahn Pharmaceuticals Inc RNN
Common Stock
|
2019-02-28 | Option exercise | 1,625 | $0.00 | |
|
Rexahn Pharmaceuticals Inc RNN
Common Stock
|
2019-01-30 | Buy | 20,000 | $0.65 | 13,000 |
|
Rexahn Pharmaceuticals Inc RNN
Stock Option (right to buy) · derivative
|
2019-01-25 | Grant | 130,000 | $0.00 | |
|
Rexahn Pharmaceuticals Inc RNN
Restricted Stock Units · derivative
|
2018-02-28 | Option exercise | 1,625 | $0.00 | |
|
Rexahn Pharmaceuticals Inc RNN
Common Stock
|
2018-02-28 | Option exercise | 1,625 | $0.00 | |
|
Rexahn Pharmaceuticals Inc RNN
Stock Option (right to buy) · derivative
|
2018-01-26 | Grant | 42,101 | $0.00 | |
|
Rexahn Pharmaceuticals Inc RNN
Stock Option (right to buy) · derivative
|
2017-01-20 | Grant | 315,000 | $0.00 | |
|
Rexahn Pharmaceuticals Inc RNN
Restricted Stock Units · derivative
|
2017-01-20 | Grant | 65,000 | $0.00 | |
|
Rexahn Pharmaceuticals Inc RNN
Stock Option (right to buy) · derivative
|
2016-07-06 | Grant | 1,200,000 | $0.00 |